| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 1.36× | 1.36× | 30.20× | 37.91× | 6.40× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.62× | 0.61× | 0.93× | 1.04× | 2.49× | ||
| 0.27× | 0.27× | 0.27× | 0.28× | 0.25× | ||
| 0.88× | 0.88× | 1.00× | 0.85× | −0.07× | ||
| 0.83× | 0.83× | 0.94× | 0.79× | −0.07× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 6.40 | 37.91 | 30.20 | 1.36 | 1.36 | |
| Working Capital Turnover | 2.49 | 1.04 | 0.93 | 0.61 | 0.62 | |
| Asset Turnover | 0.25 | 0.28 | 0.27 | 0.27 | 0.27 | |
| Cash Conversion (CFO/Net Income) | -0.07 | 0.85 | 1.00 | 0.88 | 0.88 | |
| CFO/EBITDA | -0.07 | 0.79 | 0.94 | 0.83 | 0.83 |